<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: eSS is a rat model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> characterized by fasting <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> and early <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Diabetic symptoms worsen during the second year of life as insulin release decreases </plain></SENT>
<SENT sid="2" pm="."><plain>In 12-month-old males a <z:hpo ids='HP_0006555'>diffuse hepatic steatosis</z:hpo> was detected </plain></SENT>
<SENT sid="3" pm="."><plain>We report the disturbances of <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism of the model with regard to the diabetic syndrome </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: The study was conducted in eight 12-month-old eSS male rats and seven age/weight matched eumetabolic Wistar rats fed with a complete commercial diet al libitum </plain></SENT>
<SENT sid="5" pm="."><plain>Fasting plasmatic <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, total cholesterol, low-density and <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi>, and nonesterified fatty acids levels were measured </plain></SENT>
<SENT sid="6" pm="."><plain>Very low density and intermediate-density <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> were analyzed and hepatic lipase activity was determined </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: eSS rats developed <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, indicating <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Compared with controls, diabetic rats exhibited high plasmatic levels of NEFA, <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (TG), total cholesterol (Chol) and <z:chebi fb="15" ids="39026">LDL</z:chebi>-Chol while <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol values were reduced </plain></SENT>
<SENT sid="9" pm="."><plain>eSS rats also displayed TG-rich <z:chebi fb="1" ids="39027">VLDL</z:chebi> and IDL particles without changes in hepatic lipase activity </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The nonobese eSS rats develop a syndrome characterized by <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> disorders and <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo> that may provide new opportunities for studying the pathogenesis of human type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>